Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

Global animal health market led by Pfizer, Merck and Elanco

Industry Sector

Healthcare and Medical

Published

16 January 2013

Author

Alex De Angelis

Type of News

Market

The global animal health market has been forecast to hit a value of US$42.9 billion by 2018, primarily driven by current unmet animal health needs and the growing need to ensure sustainable food supply.

Over the last couple of decades, animal health, especially in relation to farm animals, has been gaining in popularity as a result of the growing awareness backed by compelling scientific evidence linking animal health with human food safety and public health. In other words, the health of animals, especially in the food animal production system, has a far reaching impact on the food chain.

With consumers demanding risk-free food and with Governments across the world focused on building newer systems for superior animal health management, its opportunities galore for animal health products including animal medication.

The importance of animal health products, especially medicines, can be put into perspective by the fact that sick animals cannot produce food fit for human consumption, and the ensuing shortage of animal protein products will push up costs and trigger food inflation, while simultaneously making animal farming expensive by reducing economic sustainability and yields and by increasing the cost per kilogram of the animal product produced.Animal health

The US represents the largest region within the global animal health market, while Asia-Pacific represents the fastest growing regional market, with annual dollar sales from the region growing at a compound annual growth rate (CAGR) of approximately 10.5% through to 2018.

The animal health market is highly competitive with the top 10 players accounting for around 80% of the total market in 2011. Major market players include Pfizer, Merck, Merial, Elanco and Bayer.

Zoetis Inc, a Pfizer wholly-owned subsidiary devoted to the animal health business, will spin off and begin trading as its own entity, according to an S-1 filing with the SEC. The new offering was scheduled for the second half of 2012, and as much as 20% of the company's equity will be sold.

Zoetis is up against the likes of Elanco, Eli Lilly & Co's animal health business. Elanco helped to hold up its larger parent company in the most recent earnings quarter, staging a 32% surge in sales in the 2Q versus the year ago period to $512 million versus.

Merck is another rival in this animal healthcare space. The drugmaker giant grew its revenues for livestock and pet meds by 8% in the second quarter, and similar to Eli Lilly is steadfast in its commitment to its animal health business.

For more information on the global animal health market, see the latest research: Global Animal Health Market

Follow us on Twitter @CandMResearch

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

December Discounted Prices: Contact us to ask about our special discounts available in December

For the last month in 2014 we are offering discounted prices on a selection of new reports. Please contact us on 00 44 (0) 203 0868600 or via email (click here to email) to ask about prices and special discounts.

Available during December and the run-up to Christmas; Discounted prices on a selection of our reports.

Find all the research at the best prices. Great promotions being offered during December!

We are offering our clients substantial savings on the best research available during December. Please contact us either via emailor by calling our team to discuss your specific research needs on Tel: 00 44 (0) 203 0868600. We look forward to being able to find you the research you require at good prices.

Accessibility
Close

Contrast settings

Text size settings